United States molecular diagnostics market is projected to surpass US$ 9 billion by 2024

Access Full Research: http://www.renub.com/united-states-usa-molecular-diagnostics-market-test-volume-forecast-and-companies-35-p.php

Get Free 10% Customization in this Report.

As the evolution of innovative technologies is happening in the field of research and medicine, molecular diagnostics is growing rapidly. United States molecular diagnostics market is projected to surpass US$ 9 billion by 2024. Molecular diagnostics system is one of the hopeful systems that enable automation of extraction of high-quality nucleic acids from a wide variety of sample types and the selection of targeted, individualized treatment options. Molecular diagnostics system offers early disease detection, potentially before symptoms have even occurred.
In this report United States molecular diagnostics market has been segmented into three major categories: Oncology Test, Infectious Disease Test and Genetic Disease Test. Further, Oncology Test has been segmented into four major categories: Breast Cancer Test, Colorectal Cancer Test, Prostate Cancer Test and Other Cancer Test. Infectious Disease Test has been segmented into four major categories, namely, Virology, HAI, HPV and Critical Care Test and Genetic Test has been segmented into Blood Screening, HLA and Food Pathogen Test.

United State Molecular Diagnostics Market Shares: Overview
Our study found that both the Oncology and Infectious Test market have significant market in United States Molecular Diagnostics Market. In Molecular Oncology Test market; Breast cancer dominates the market on the other side in Molecular Infectious Test market; Virology is leading all other segments. While in terms of Tests Volume; Genetics test is leading all way ahead from Infectious and Oncology Test owing to Food Pathogen Test Volume.
The top players in United States Molecular Diagnostics Market includes several familiar names such as Roche, Hologic, Becton Dickinson, Myraid Genetics, Qiagen and Abbott, Siemens, bioMérieux and Cepheid.
Renub Research study titled “United States Molecular Diagnostics Market, Test Volume Forecast & Companies: Oncology Test (Breast Cancer, Colorectal Cancer, Prostate Cancer, Others) Infectious Diseases (Virology Test, HPV Test, HAI Test, Critical Care Test) Genetic Test (Blood Screening, Food Pathogen Test, Tissue Typing HLA Test)” provides a comprehensive assessment of the fast–evolving, high–growth United States Molecular Diagnostics Market. This is the 2nd edition of the report published by Renub Research.
This 146 page report with 87 Figures and 4 Tables studies the United States Molecular Diagnostics from 4 view points:
1) Molecular Diagnostics Market and Forecast
2) Segments Market & Forecast
3) Segments Test Volume & Forecast
4) Company Molecular Diagnostics Sales & Forecast

United States Molecular Diagnostics Market & Test Volume – Application Segment Analysis (2010 – 2024)
1. Oncology Test
a) Breast Cancer
b) Colorectal Cancer
c) Prostate Cancer
d) Others

2. Infectious Diseases
a) Virology Test
b) HPV Test
c) HAI Test
d) Critical Care Test

3. Genetic Test
a) Blood Screening
b) Food Pathogen Test
c) Tissue Typing (HLA Test)

Company Sales Analysis (2010 – 2024)
1. Roche
2. Abbott
3. Myriad Genetics
4. BioMerieux
5. Qiagen
6. Hologic Inc.
7. Becton Dickinson
8. Siemens
9. Cepheid
10. Others

Content from Old Report is given below:
The user can buy this report in Chapters from Purchase by Chapter section given above

United States Molecular Diagnostics Market & Future Forecast to 2018 Overview

Molecular diagnostics is a rapidly–advancing area of research and medicine, with new technologies and applications being added continuously. Molecular diagnostics is the promising area which can transform disease diagnosis, as diagnosis based on symptoms and use of surrogate markers is replaced by genomic and proteomic analysis. This fundamental shift offers the promise for early disease detection, potentially before symptoms have even occurred.
United States molecular diagnostic market for 2018 is anticipated to more than double from its current value in 2013. In United States molecular diagnostic market, infectious disease controls the highest market share in 2013.
But in terms of test volume food pathogen testing takes the lead pushing infectious disease at number two position.
Molecular oncology tests have emerged as a significant rapidly growing market segment. In the current medical diagnostics market, molecular diagnostics for cancer testing offers one of the brightest areas for growth and innovation. United States constitutes the largest regional market for blood screening and blood products. Molecular diagnostics is also starting to emerge as an important tool for HLA Testing, Food Pathogen Detection Testing and other disease areas.
In companies market share Hologic Inc., Myriad Genetics and Becton Dickinson together these 3 companies control more than 50% market share for 2013. However Becton Dickinson is expected to lose its market share gradually and Roche is expected to take its place by 2018.

United States Molecular Diagnostics Market & Test Volume – Application Segment Analysis (2010 – 2018)
1. Oncology Testing
a) Breast Cancer
b) Colorectal Cancer
c) Prostate Cancer
d) Others

2. Infectious Diseases
a) Virology Testing
b) HPV Testing
c) HAI Testing
d) Critical Care Testing

3. Genetic Testing
4. Blood Screening
5. Food Pathogen Testing
6. Tissue Typing (HLA Testing)

United States Molecular Diagnostics – Company Wise Sales Analysis (2010 – 2018)
1. Roche
2. Abbott
3. Myriad Genetics
4. BioMerieux
5. Qiagen
6. Hologic Inc.
7. Becton Dickinson
8. Siemens
9. Cepheid
10. Others

Renub Research study titled “United States (USA)-Molecular Diagnostics Market, Test Volume Forecast & Companies” provides a comprehensive assessment of the fast–evolving, high–growth Global Molecular Diagnostics Market. This 128 page report with 87 Figures studies the United States Molecular Diagnostics from 4 view points: 1) Market and Forecast 2) Application Wise Market & Forecast 3) Application Wise Test Volume & Forecast 4) Company Wise Molecular Diagnostics Sales & Forecast.

Contact Us
Rajat Gupta
Sr. Marketing Manager
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com

Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.

225 Kristie Ln, Roswell, GA 30076, United States

This release was published on openPR.